Global Organ-On-Chips Market Reports give a Key study on the industry status of the Organ-On-Chips Industry Manufacturer with the specific statistics, meaning, definition, SWOT Analysis, expert opinion, and recent development across the globe. The research report also covers the Market Size, Price, Sales, Revenue, Market share, Gross Margin, growth rate, and cost structure. The report aims to give an additional sample of the latest scenario, economic slowdown, and Covid-19 impact on overall Industry.
The Organ-On-Chips Market size was valued at USD 62.62 million in 2022 and is expected to reach USD 386.29 million by 2030, at a CAGR of 29.74% from 2022 to 2030.
Get Sample PDF Brochure with Table of Contents and Important Figures @
https://www.contrivedatuminsights.com/request-sample/4130/
Organ-on-a-chip is a fake organ that works like a real organ. It is a device for growing cells in 3D that has many channels and stimulates organ function, mechanisms, and physiological responses. When researchers use lab-on-a-chip (LOC) and cell biology together, they can study human physiology in organ-specific settings. This has led to the creation of a new complex human bio model that can be used in the lab. The chip makes a small hole in organs like the lungs, gut, brain, liver, and heart so that blood and air can flow through. These devices are made on a microchip with chambers that are constantly filled with blood and populated with living cells to trigger physiology at the level of tissues and organs. With the help of silica gel, an organ chip is a device used to grow organs inside the body.
Competitive Landscape and Global Market Share Analysis:
Mimetas (Netherlands), Emulate (US), InSphero (Switzerland), CN Bio Innovations, BioIVT, Kirkstall, Visikol, SynVivo, AxoSim, Nortis, and others., Others
Industry Development:
- In September 2022, in vitro model provider Emulate Inc. announced a new application of adeno-associated virus transduction for a liver-on-a-chip that helps researchers test the safety and efficacy of adeno-associated virus vectors in relevant liver models in Produces result in humans within weeks.
- In May 2021, CN Bio, the preeminent creators of single- and multi-organ microphysiology-on-a-chip systems that improve the accuracy and efficiency of drug discovery, revealed that their research relationship with the U.S. Food and Drug Administration has been extended by another three years .
Market Segmentation:
By Type
- Heart on chip
- Human on chip
- Intestine on chip
- Kidney on chip
- Liver on chip
- Lung on chip
On the Basis of End Use:
- Academic
- Research Institute
- Pharma companies
The report on the Organ-On-Chips market covers the following region (country) analysis:
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- South America (Mexico, Brazil, Argentina, Columbia, Rest of South America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
Regional Insights:
In 2020, 55.7% of the global market for Organ-On-Chips will come from North America. Europe, Asia, and the rest of the world will follow. The Organ-On-Chips market will grow the fastest in Asia and the rest of the world between 2020 and 2025, with CAGRs of 34.1% and 33.0%, respectively. Europe and North America will come next. Their CAGRs are forecast to be 28.5% and 26.9%, respectively.
North America is projected to lead the market in 2021, with Europe coming in second. This is expected to stay the same during the forecast period. This is because of things like the fact that there are new and improved organ chips on the market and a lot of big pharmaceutical companies there. Also, good government efforts for funding and planning basic drug research and development.
Following are the major TOC of the Organ-On-Chips Market:
Chapter 1: Organ-On-Chips Market Overview
Chapter 2: Global Economic Impact on Industry
Chapter 3: Global Organ-On-Chips Market Competition by Manufacturers
Chapter 4: Global Production, Profits (Value) by Region
Chapter 5: Global Supply (Production), Import, Export, Consumption, by Regions
Chapter 6: Global Price Trend by Type, Revenue (Value), Production
Chapter 7: Manufacturing Cost Analysis
Chapter 8: Global Market Analysis by Application
Chapter 9: Industrial Chain and Downstream Buyers, Sourcing Strategy
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Global Organ-On-Chips Market Forecast
Buy Now:
https://www.contrivedatuminsights.com/buy/4130/
Key Reasons to Purchase Organ-On-Chips Market report:
The report provides a thorough examination of the manufacturing methods, as well as ideas to reduce development risk, major market growth challenges and strategic inputs to overcome the market threats.
In-depth market analysis and an overview of the global Organ-On-Chips Market trend and commercial landscape are included in the report. In addition, the report discusses the effect of COVID-19 on the market.
Reader can acquire a better interpretation of the Organ-On-Chips Market forecast’s future view and opportunities from the report.
The report contains an analysis of recent developments as well as profiles of important market leaders and key players.
To gain an understanding of the market strategies by the leading market players in the Organ-On-Chips
The report analyses the most important driving and restraining factors in the industry, as well as their impact on global market growth.
About Us:
Contrive Datum Insights (CDI) is a global delivery partner of market intelligence and consulting services to officials in various sectors including investment, information technology, telecommunications, consumer technology, and manufacturing markets. CDI helps investment communities, business executives and IT professionals make accurate, statistically-based decisions on technology purchases and promote strong growth tactics to maintain market competitiveness. Composed of a team of more than 100 analysts and a cumulative market experience of more than 200 years, Contrive Datum Insights guarantees the delivery of industry knowledge combined with global and national experience.
Contact Us:
Anna B. (Head Of sales) | Contrive Datum Insights
Contact No- +91 9834816757 / +1 2152974078
[email protected]